Shopping Cart
- Remove All
- Your shopping cart is currently empty
STT3A/B-IN-1, an orally active inhibitor of STT3A/B, exhibits antiviral properties and elevates the expression levels of the DERL3 gene. This compound holds promise for the study of viral diseases, including cancer and neurodegenerative disorders.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | STT3A/B-IN-1, an orally active inhibitor of STT3A/B, exhibits antiviral properties and elevates the expression levels of the DERL3 gene. This compound holds promise for the study of viral diseases, including cancer and neurodegenerative disorders. |
Molecular Weight | 355.45 |
Formula | C19H21N3O2S |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.